Virtu Financial’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,709
| Closed | -$10K | – | 2145 |
|
|
2023
Q1 | $10K | Buy |
+3,709
| New | +$10K | ﹤0.01% | 1348 |
|
|
2022
Q3 | – | Sell |
-3,286
| Closed | -$17K | – | 2322 |
|
|
2022
Q2 | $17K | Buy |
+3,286
| New | +$17K | ﹤0.01% | 1364 |
|
|
2021
Q4 | – | Sell |
-4,517
| Closed | -$54K | – | 2262 |
|
|
2021
Q3 | $54K | Sell |
4,517
-10,738
| -70% | -$128K | ﹤0.01% | 1263 |
|
|
2021
Q2 | $411K | Sell |
15,255
-3,779
| -20% | -$102K | 0.04% | 564 |
|
|
2021
Q1 | $548K | Buy |
19,034
+4,701
| +33% | +$135K | 0.04% | 478 |
|
|
2020
Q4 | $224K | Buy |
14,333
+11,535
| +412% | +$180K | 0.02% | 789 |
|
|
2020
Q3 | $27K | Sell |
2,798
-2,460
| -47% | -$23.7K | ﹤0.01% | 899 |
|
|
2020
Q2 | $118K | Buy |
+5,258
| New | +$118K | 0.01% | 844 |
|
|
2018
Q3 | – | Sell |
-856
| Closed | -$23K | – | 2313 |
|
|
2018
Q2 | $23K | Buy |
856
+275
| +47% | +$7.39K | ﹤0.01% | 1844 |
|
|
2018
Q1 | $28K | Sell |
581
-2,444
| -81% | -$118K | ﹤0.01% | 1791 |
|
|
2017
Q4 | $137K | Buy |
3,025
+2,613
| +634% | +$118K | 0.01% | 1814 |
|
|
2017
Q3 | $28K | Buy |
+412
| New | +$28K | ﹤0.01% | 2298 |
|